Cargando…

FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is, by far, the most prevalent and fatal kind of kidney cancer. Ferrochelatase (FECH) is an enzyme that performs a significant function in the onset and progression of many distinct kinds of malignant tumors. Nevertheless, its predictive usefulness...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Guanghui, Li, Qing, Luo, Yang, Liu, Yufeng, Liu, Dawei, li, Bin, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436586/
https://www.ncbi.nlm.nih.gov/pubmed/36059798
http://dx.doi.org/10.1155/2022/8943643
_version_ 1784781400669421568
author Zhong, Guanghui
Li, Qing
Luo, Yang
Liu, Yufeng
Liu, Dawei
li, Bin
Wang, Tao
author_facet Zhong, Guanghui
Li, Qing
Luo, Yang
Liu, Yufeng
Liu, Dawei
li, Bin
Wang, Tao
author_sort Zhong, Guanghui
collection PubMed
description BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is, by far, the most prevalent and fatal kind of kidney cancer. Ferrochelatase (FECH) is an enzyme that performs a significant function in the onset and progression of many distinct kinds of malignant tumors. Nevertheless, its predictive usefulness in renal clear cell carcinoma (RCC) has not yet been fully investigated. METHODS: FECH expression in ccRCC and healthy adjoining tissues was primarily screened utilizing data sourced from The Cancer Genome Atlas (TCGA) and subsequently validated using data from an independent cohort derived from the Gene Expression Omnibus (GEO) and the Human Protein Atlas HPA databases. The relationship among FECH expression, clinicopathological parameters, and overall survival (OS) was assessed utilizing multivariate analysis and Kaplan–Meier survival curves. Additionally, the protein networks with FECH interaction were constructed with the aid of the online Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). Gene ontology (GO) analysis, and gene set enrichment analysis (GSEA) were conducted based on TCGA data, and a single-sample GSEA was utilized to explore the link between FECH expression and the infiltration status of immune cells in the tumor. The Gene Expression Profiling Interactive Analysis (GEPIA) and TIMER databases were utilized to investigate the relationships of FECH expression with the infiltrating immune cells and the matching gene marker sets. RESULTS: FECH expression was shown to be substantially lowered in ccRCC tumors as opposed to that observed in normal tissues (p < 0.05). Lower levels of FECH expression were shown to have a strong association with higher grades of cancer and more advanced TNM stages. The findings of multivariate and univariate analyses illustrated that the OS in patients with ccRCC with low FECH expression is shorter in contrast with that in the high FECH expression group (p < 0.05). It was discovered that CPOX and frataxin are key proteins that interact with FECH. ccRCC with FECH deficiency was linked to the lack of infiltrating immune cells and their respective marker sets, which included CD4+ T cells. CONCLUSION: In ccRCC, decreased FECH expression was linked to disease progression, unfavorable prognosis, and impaired immune cell infiltration.
format Online
Article
Text
id pubmed-9436586
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94365862022-09-02 FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma Zhong, Guanghui Li, Qing Luo, Yang Liu, Yufeng Liu, Dawei li, Bin Wang, Tao J Oncol Research Article BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is, by far, the most prevalent and fatal kind of kidney cancer. Ferrochelatase (FECH) is an enzyme that performs a significant function in the onset and progression of many distinct kinds of malignant tumors. Nevertheless, its predictive usefulness in renal clear cell carcinoma (RCC) has not yet been fully investigated. METHODS: FECH expression in ccRCC and healthy adjoining tissues was primarily screened utilizing data sourced from The Cancer Genome Atlas (TCGA) and subsequently validated using data from an independent cohort derived from the Gene Expression Omnibus (GEO) and the Human Protein Atlas HPA databases. The relationship among FECH expression, clinicopathological parameters, and overall survival (OS) was assessed utilizing multivariate analysis and Kaplan–Meier survival curves. Additionally, the protein networks with FECH interaction were constructed with the aid of the online Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). Gene ontology (GO) analysis, and gene set enrichment analysis (GSEA) were conducted based on TCGA data, and a single-sample GSEA was utilized to explore the link between FECH expression and the infiltration status of immune cells in the tumor. The Gene Expression Profiling Interactive Analysis (GEPIA) and TIMER databases were utilized to investigate the relationships of FECH expression with the infiltrating immune cells and the matching gene marker sets. RESULTS: FECH expression was shown to be substantially lowered in ccRCC tumors as opposed to that observed in normal tissues (p < 0.05). Lower levels of FECH expression were shown to have a strong association with higher grades of cancer and more advanced TNM stages. The findings of multivariate and univariate analyses illustrated that the OS in patients with ccRCC with low FECH expression is shorter in contrast with that in the high FECH expression group (p < 0.05). It was discovered that CPOX and frataxin are key proteins that interact with FECH. ccRCC with FECH deficiency was linked to the lack of infiltrating immune cells and their respective marker sets, which included CD4+ T cells. CONCLUSION: In ccRCC, decreased FECH expression was linked to disease progression, unfavorable prognosis, and impaired immune cell infiltration. Hindawi 2022-08-25 /pmc/articles/PMC9436586/ /pubmed/36059798 http://dx.doi.org/10.1155/2022/8943643 Text en Copyright © 2022 Guanghui Zhong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhong, Guanghui
Li, Qing
Luo, Yang
Liu, Yufeng
Liu, Dawei
li, Bin
Wang, Tao
FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
title FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
title_full FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
title_fullStr FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
title_full_unstemmed FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
title_short FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
title_sort fech expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436586/
https://www.ncbi.nlm.nih.gov/pubmed/36059798
http://dx.doi.org/10.1155/2022/8943643
work_keys_str_mv AT zhongguanghui fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT liqing fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT luoyang fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT liuyufeng fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT liudawei fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT libin fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma
AT wangtao fechexpressioncorrelateswiththeprognosisandtumorimmunemicroenvironmentinclearcellrenalcellcarcinoma